Asima Health is developing a multi-cancer blood test to reduce the human and financial burden of cancer testing

Our innovative technology can quickly rule out cancer or identify those at risk and in need of colonoscopy, mammography, etc., with a simple blood test.

Our platform technology is portable which means that the test can be accessed through your local diagnostic lab, as part of routine blood work.

Our pan-genomic test can simultaneously detect multiple cancers which means primary & secondary cancers can be caught from a single blood draw.

More people are surviving cancer. Between 1991 & 2020, the death rate for all cancers in the U.S. declined by 33%. Currently there are 18 million cancer survivors in the U.S and this number is projected to become 26 million by 2040.

Cancer survivors follow up with their doctor every 3-12 mos for a physical exam & testing. The standard of care involves tests such as mammograms and colonoscopy, that are invasive, expensive, slow to get results, and have low diagnostic yield.

Cancer is among the leading causes of death worldwide. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide.

Asima is an early stage cancer diagnostic startup that aims to commercialize novel, patient-centric, and accessible genomic technologies. Our first product is a pan-genomic cancer surveillance testing platform.

We aim to disrupt, democratize and decentralize the cancer surveillance market, bringing about significant changes to the way cancer tests are accessed by every individual in our society, especially those in marginalized communities.

Asima is actively seeking collaborations to write grants, perform clinical studies, carry out research investigations and troubleshoot ideas that help meet our objectives.

Asima believes in delivering timely, inexpensive and easy access to cancer diagnostics. Effectiveness in delivering technological advancements in these areas not just to populations centred around urban locations but to underserved populations so that as many lives may be saved, as possible.